SAB-176

BIOLOGICAL2 trials

Sponsors

SAb Biotherapeutics, Inc.

Conditions

InfluenzaInfluenza A H1N1Influenza Type AInfluenza Type B

Phase 1

Safety, Tolerability, and Pharmacokinetics of SAB-176 in Healthy Participants

CompletedNCT04471038

SAb Biotherapeutics, Inc.Influenza, Influenza Type A, Influenza Type B

Start: 2020-07-29End: 2021-04-19Updated: 2025-01-06

Phase 2

Study of SAB-176 in Healthy Adult Participants

CompletedNCT04850898

SAb Biotherapeutics, Inc.Influenza A H1N1

Start: 2021-06-23End: 2021-10-08Updated: 2025-01-22